Senior Clinician, Director LID Clinical Studies Unit
National Institutes of Health
Dr. Memoli is a graduate of the College of William and Mary and received his Masters Degree in Microbiology from Thomas Jefferson University in Philadelphia, PA. He then received his MD from St George’s University School of Medicine. He completed a residency in internal medicine at the Washington Hospital Center Georgetown University Internal Medicine Program in Washington, DC. After completing an infectious disease fellowship in NIAID at the National Institutes of Health, Dr. Memoli developed a clinical/translational research program to study influenza and other respiratory viruses in the Laboratory of Infectious Diseases. He now serves as the Director of the LID Clinical Studies Unit.
Dr. Memoli has taken part in the research response for multiple emerging infectious diseases including pandemic influenza, Ebola, and Zika. His main focus is healthy volunteer influenza challenge models and the development of improved influenza vaccines. He specializes in performing unusual and unique clinical trials and has lead a number of such trials including phase I and II trials of novel vaccines/therapeutics targeting influenza as well as mosquito borne diseases. Other interests include clinical pathogenesis of viral infections in immunocompromised patients and other special at risk populations, intrahost evolution of influenza, antiviral resistance, immune correlates of protection against respiratory viruses, modes of transmission, and molecular diagnostics.
Disclosure: Nothing to disclose
Friday, October 4
11:20 AM – 11:45 AM